Stanford Surgery Clinical Trials
-
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer
Stanford is currently accepting patients for this trial. -
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
Stanford is currently accepting patients for this trial. -
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
Stanford is currently accepting patients for this trial. -
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Stanford is currently accepting patients for this trial. -
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
Stanford is currently accepting patients for this trial. -
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
Stanford is currently accepting patients for this trial. -
Limiting AAA With Metformin (LIMIT) Trial
Stanford is currently accepting patients for this trial. -
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Stanford is currently accepting patients for this trial. -
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stanford is currently accepting patients for this trial. -
Abdominal Scar Improvement in Microsurgical Breast Reconstruction
Stanford is currently accepting patients for this trial.